The FDA has awarded two $250,000 grants to fund research projects in fiscal year 2019 to help target and define durations of use for certain medically important antimicrobial drugs administered in animal feed.
Veterinarians and livestock producers have adapted to significant changes in antimicrobial regulations, and change will continue as the FDA works through its five-year plan for antimicrobial stewardship.
Veterinarians will, over the next five years, become more involved in overseeing the use of all forms of medically important antimicrobials used in livestock.
In a new report, the Government Accounting Agency (GAO) outlines the current lack of information on the use of animal-drug compounding, and calls on the FDA to modify its policies regarding compounded drugs.
Merck Animal Health releases a statement in response to a Texas Tech scientist's article that raises concern over the use of beta agonists in beef cattle.
Since the FDA launched its new veterinary feed directive (VFD) policies in January 2017, numerous producer questions have centered on the use of chlortetracycline (CTC) for control of anaplasmosis.
A meta-analysis published in a recent issue of Bovine Practitioner suggests feedyards could potentially have significantly fewer repeat treatment courses for BRD if they use Draxxin Injectable Solution upon arrival.
